- Home
- IXHL vs GLMD Comparison
IXHL vs GLMD Comparison
Compare IXHL & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- GLMD
- Stock Information
- Founded
- IXHL 2001
- GLMD 2000
- Country
- IXHL Australia
- GLMD Israel
- Employees
- IXHL N/A
- GLMD N/A
- Industry
- IXHL
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- GLMD Health Care
- Exchange
- IXHL Nasdaq
- GLMD Nasdaq
- Market Cap
- IXHL 3.6M
- GLMD 3.0M
- IPO Year
- IXHL N/A
- GLMD 2014
- Fundamental
- Price
- IXHL $0.18
- GLMD $1.51
- Analyst Decision
- IXHL
- GLMD Hold
- Analyst Count
- IXHL 0
- GLMD 1
- Target Price
- IXHL N/A
- GLMD N/A
- AVG Volume (30 Days)
- IXHL 146.9M
- GLMD 255.6K
- Earning Date
- IXHL 05-15-2025
- GLMD 06-17-2025
- Dividend Yield
- IXHL N/A
- GLMD N/A
- EPS Growth
- IXHL N/A
- GLMD N/A
- EPS
- IXHL N/A
- GLMD N/A
- Revenue
- IXHL $98,000.00
- GLMD N/A
- Revenue This Year
- IXHL $3,817.06
- GLMD N/A
- Revenue Next Year
- IXHL $66.67
- GLMD N/A
- P/E Ratio
- IXHL N/A
- GLMD N/A
- Revenue Growth
- IXHL N/A
- GLMD N/A
- 52 Week Low
- IXHL $0.08
- GLMD $1.15
- 52 Week High
- IXHL $3.55
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- IXHL 42.72
- GLMD 56.28
- Support Level
- IXHL $0.18
- GLMD $1.36
- Resistance Level
- IXHL $0.21
- GLMD $1.60
- Average True Range (ATR)
- IXHL 0.03
- GLMD 0.09
- MACD
- IXHL 0.01
- GLMD 0.03
- Stochastic Oscillator
- IXHL 6.64
- GLMD 79.07
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.